论文部分内容阅读
我院用以卡铂为主的抗癌药物行支气管动脉灌注化疗治疗肺癌８３例。其中小细胞肺癌２５例，ＣＲ＋ＰＲ２１例，有效率８４％；非小细胞肺癌５８例，ＣＲ＋ＰＲ３Ｏ例，有效率５１．７％。此法具有可将药物直接灌入肿瘤的供血血管患侧支气管动脉，有效地选择性地形成肿瘤药物的高浓度，增强抗癌作用；并能一次性大剂量联合给药，使用方便，疗效高，毒副反应低，适应证广泛等优点。
In our hospital, 83 cases of lung cancer were treated with bronchial arterial infusion chemotherapy using carboplatin-based anticancer drugs. There were 25 patients with small cell lung cancer, 21 patients with CR+PR and 84% effective rate; 58 patients with non-small cell lung cancer and CR+PR3O patients with an effective rate of 51.7%. This method has the ability to directly inject drugs directly into the bronchial arteries of the affected blood vessels of the tumor, efficiently and selectively form high concentrations of drugs for cancer, enhance the anticancer effect, and can be combined in a large dose at a time, with convenient use and high curative effect. , Low toxicity, wide indications and other advantages.